The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development: Part 3—Introduction to Pharmacodynamic Modeling Methods
Open accessAbstract
Population pharmacodynamic (PD) models describe the time course of drug effects, relating exposure to response, and providing a more robust understanding of drug action than single assessments. PD models can test alternative dose regimens through simulation, allowing for informed assessment of potential dose regimens and study designs. This is the third paper in a three‐part series, providing an introduction into methods for developing and evaluating population PD models. Example files are available in the Supplementary Data. CPT Pharmacometrics Syst. Pharmacol. (2014) 3, e88; doi:10.1038/psp.2013.71; published online 2 January 2014
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McLachlan, G., & Peel, D. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471721182 · Cited by 10,991
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Bergstrand, M., Hooker, A. C., Wallin, J. E., & Karlsson, M. O. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9255-z · Cited by 1,428
Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine
Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., & Ham, J. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979253358 · Cited by 1,134
Mould, D., & Upton, R. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.14 · Cited by 897
Self-citationComparison of four basic models of indirect pharmacodynamic responses
Dayneka, N. L., Garg, V., & Jusko, W. J. (1993) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061691 · Cited by 821
Learning versus confirming in clinical drug development*
Sheiner, L. B. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90160-0 · Cited by 633
Sheiner, L. B., & Beal, S. L. (1980) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060053 · Cited by 566
Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development
Mould, D., & Upton, R. (2012) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.4 · Cited by 544
Self-citationModel of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs
Friberg, L. E., Henningsson, A., Maas, H., Nguyen, L., & Karlsson, M. O. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.140 · Cited by 534
Principles: Receptor theory in pharmacology
Kenakin, T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.012 · Cited by 412
Bouillon, T. W., Bruhn, J., Radulescu, L., Andresen, C., Shafer, T. J., Cohane, C., & Shafer, S. L. (2004) · Anesthesiology · doi:10.1097/00000542-200406000-00006 · Cited by 375
Zero‐Altered and other Regression Models for Count Data with Added Zeros
Heilbron, D. C. (1994) · Biometrical Journal · doi:10.1002/bimj.4710360505 · Cited by 375
Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance
Zhang, L., Beal, S. L., & Sheiner, L. B. (2003) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/b:jopa.0000012998.04442.1f · Cited by 369
Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective
Dumas, E. O., & Pollack, G. M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9056-1 · Cited by 269
Sheiner, L. B. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409015063 · Cited by 257
Drug Metabolism and Drug Toxicity
Ames, M. M. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60310-3 · Cited by 246
Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin
Nagashima, R., O'Reilly, R. A., & Levy, G. (1969) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196910122 · Cited by 230
The utility of modeling and simulation in drug development and regulatory review
Huang, S.-M., Abernethy, D. R., Wang, Y., Zhao, P., & Zineh, I. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23570 · Cited by 206
A PHARMACODYNAMIC MODEL FOR PANCURONIUM
HULL, C. J., BEEM, H. B. H. V., MCLEOD, K., SIBBALD, A., & WATSON, M. J. (1978) · British Journal of Anaesthesia · doi:10.1093/bja/50.11.1113 · Cited by 195
Organization of circadian functions: interaction with the body
Buijs, R. M., Scheer, F. A., Kreier, F., Yi, C., Bos, N., Goncharuk, V. D., & Kalsbeek, A. (2006) · Progress in Brain Research · doi:10.1016/s0079-6123(06)53020-1 · Cited by 188
The Biological Clock: The Bodyguard of Temporal Homeostasis
Perreau‐Lenz, S., Pévet, P., Buijs, R. M., & Kalsbeek, A. (2004) · Chronobiology International · doi:10.1081/cbi-120027984 · Cited by 150
Sharma, A., Ebling, W. F., & Jusko, W. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980171q · Cited by 132
Yoshida, K. J., Maeda, K., & Sugiyama, Y. (2012) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140309 · Cited by 123
Mould, D. R., Baumann, A., Kuhlmann, J., Keating, M. J., Weitman, S., Hillmen, P., Brettman, L. R., Reif, S., & Bonate, P. L. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02914.x · Cited by 116
Self-citationA Joint Model for Nonlinear Longitudinal Data with Informative Dropout
Hu, C., & Sale, M. E. (2003) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1023249510224 · Cited by 107
Mould, D. R. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.122 · Cited by 94
Self-citationDavda, J. P., & Hansen, R. J. (2010) · mAbs · doi:10.4161/mabs.2.5.12833 · Cited by 93
Pillai, G. C., Gieschke, R., Goggin, T. K., Jacqmin, P., Schimmer, R. C., & Steimer, J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02224.x · Cited by 87
Nieforth, K. A., Nadeau, R., Patel, I. H., & Mould, D. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90003-x · Cited by 81
Self-citationSimultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam
Mould, D. R., DeFeo, T. M., Reele, S. B., Milla, G. M. D. M., Limjuco, R. A., Crews, T., Choma, N., & Patel, I. H. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90070-5 · Cited by 66
Self-citationReview of Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C
Wilby, K. J., Partovi, N., Ford, J., et al. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/751057 · Cited by 66
Yeo, K. R., Jamei, M., & Rostami‐Hodjegan, A. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.4 · Cited by 63
Krzyżański, W., Wiczling, P., Lowe, P. J., Pigeolet, E., Fink, M., Berghout, A., & Balser, S. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010376966 · Cited by 54
More efficient clinical trials through use of scientific model-based statistical tests
Jonsson, E. N. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129307 · Cited by 51
Pharmacodynamic model of topotecan-induced time course of neutropenia.
Zamboni, W. C., D’Argenio, D. Z., Stewart, C. F., MacVittie, T., Delauter, B. J., Farese, A. M., Potter, D. M., Kubat, N. M., Tubergen, D. G., & Egorin, M. J. (2001) · PubMed · Cited by 48
Chang, C., Byon, W., Lu, Y., Jacobsen, L. K., Badura, L. L., Sawant‐Basak, A., Miller, E. L., Liu, J., Grimwood, S., Wang, E. Q., et al. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9296-3 · Cited by 45
Using Disease Progression Models as a Tool to Detect Drug Effect
Mould, D. R., Denman, N. G., & Duffull, S. B. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100228 · Cited by 44
Self-citationAndresen, T., Upton, R. N., Foster, D. J. R., Christrup, L. L., Arendt‐Nielsen, L., & Drewes, A. M. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00649.x · Cited by 43
Self-citationKinetics of drug action: An overview
Levy, G. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90057-6 · Cited by 25
Friberg, L. E., Vermeulen, A., Petersson, K., & Karlsson, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.234 · Cited by 25
Frame, B. C., Miller, R., & Hutmacher, M. M. (2009) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-009-9137-5 · Cited by 22
A physiologically-based recirculatory meta-model for nasal fentanyl in man
Upton, R. N., Foster, D. J. R., Christrup, L. L., Dale, O., Moksnes, K., & Popper, L. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9268-y · Cited by 14
Self-citationAnalyzing Multi-Response Data Using Forcing Functions
Zhang, L., & Sheiner, L. B. (2005) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-005-0065-8 · Cited by 4
Cited by
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
Nguyen, T. H. T., Mouksassi, M., Holford, N., Al‐Huniti, N., Freedman, I., Hooker, A. C., John, J., Karlsson, M. O., Mould, D. R., Pérez Ruixo, J. J., et al. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12161 · Cited by 402
Self-citationMarques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., & Vale, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030332 · Cited by 390
Workgroup, E. M., Marshall, S., Burghaus, R., Cosson, V, Cheung, S., Chenel, M., DellaPasqua, O., Frey, N., Hamrén, B., Harnisch, L., et al. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12049 · Cited by 373
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Saari, T. I., Strang, J., & Dale, O. (2024) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01355-6 · Cited by 77
Metadata
- Authors
- Upton, R., & Mould, D.
- Venue
- CPT: Pharmacometrics & Systems Pharmacology
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 3
- Issue
- 1
- Pages
- 1-16
- ISSN
- 2163-8306 (ISSN-L)
- OpenAlex
- W4238048406
- Cited by
- 265
- References
- 45
- FWCI
- 14.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.